The Megyn Kelly Show - Trump's Newsy Cabinet Meeting, GLP-1 Drugs and Cancer, NASA Eyes Return to Moon: AM Update 5/28

Episode Date: May 28, 2026

President Trump uses a wide-ranging White House cabinet meeting to tout his administration’s record, press Iran to make a deal, address energy concerns, and respond to the latest security scare near the White House. Former Attorney General Pam Bondi reveals she is being treated for thyroid cancer as Axios reports she is returning to the Trump administration as a liaison on the president’s science and technology advisory council. A new Cleveland Clinic study finds GLP-1 drugs like Ozempic and Mounjaro are associated with slower progression in several major cancers, though researchers caution the findings do not prove the drugs caused the improved outcomes. NASA announces a new round of lunar missions and private-sector contracts aimed at testing the landers, vehicles, cargo systems, and survival infrastructure needed to return astronauts to the Moon and eventually reach Mars.   SelectQuote: Compare top‑rated life insurance options. Visit https://SelectQuote.com/megyn to get the right coverage at the right price.   Cozy Earth: This Memorial Day, visit https://www.CozyEarth.com & Use code MEGYN for up to 30% off Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Good morning, everyone. I'm Emily Dachinsky, host of After Party and the Megan Kelly Wrapup show on SiriusXM Channel 111. It's Thursday, May 28th, 2026. This is your AM update. They thought they were going to outweigh me, you know, we'll outweigh him. He's got the midterms. I don't care about the midterms. President Trump hosting a cabinet meeting with Iran high on the agenda as pressure mounts to make a deal. Former Attorney General Pam Bondi reveals a cancer diagnosis as she prepares to return to the White House in a different capacity. New findings show OZembeck-style drugs could play a role in slowing the progression of certain cancers. We're leveraging the NASA playbook from the 1960s, figuring out what works and what doesn't in this epic science of survival. And NASA announcing details on the mission to return humans to the moon. All that more coming up in just a moment on your AM update.

Time for some life talk. You probably have life insurance, but you might be paying too much for too little coverage. And did you know if you get it through your employer and then you're laid off that you could lose your coverage? It's scary to think about. But it's simple to fix, thanks to Select Quote. For over 40 years, Select Quote has been one of the most trusted insurance brokers out there, helping more than 2 million Americans secure over $700 billion in coverage. Unlike one-size-fits-all life insurance companies, select quotes licensed agents work for you for free.

In as little as 15 minutes, they will compare policy. from top-rated carriers to find the best fit for your health and budget. Head to selectquote.com and a licensed agent will find the right policy for you. Get the right life insurance for you for less and save more than 50% at selectquote.com slash Megan. Save more than 50% on term life insurance at selectquote.com slash Megan today to get started. President Trump holding a cabinet meeting yesterday originally expected to convene at Camp David in Maryland before weather concerns shifted the gathering back to the White House. The president using the cabinet meeting to project strength,

rattling off what he describes as major wins. We took the most dangerous, unsaved, violent, and open border in the world and created the most secure border in the history of our country. In 2025, we achieved the largest drop in the murder rate ever recorded. Fentanyl coming across our border is now down by 61%. Thanks to our Republican majorities in Congress, we passed the largest tax cuts in American history. The stock market has set 68 all-time record highs since the election.

The average 401K is up almost $30,000 since I took office. We're delivering record-setting discounts on prescription drugs. We made the largest ever investment in U.S. military $1 trillion, and we're asking actually for $1.5 trillion for the coming year. And we have the strongest military anywhere in the world, as you know. the war with Iran taking up a significant portion of the meeting, as the White House faces continued pressure to bring the conflict to an end. Over the weekend, U.S. and Iranian officials trading public signals about a possible breakthrough, but no deal materializing. On Monday, U.S. forces striking

Iranian missile sites in boats that CENTCOM says were laying mines in the Strait of Hormuz. U.S. military officials describing the strikes as self-defense, while Iranian officials accused Washington of violating the ceasefire. President Trump insisting the president. is on Iran to come to the table. It looks like they want to just make a deal. They want to, they, they have, I don't think they have a choice. They're just going back to the internet because they're getting clobbered. Their economy is in free fall.

They have 250% inflation. Their money has no value. Their whole economic system is broken down. They thought they were going to outweigh me, you know. We'll outweigh him. He's got the midterms. I don't care about the midterms. Look what happened last night.

That was the prelude to the midterms. People understand it. They know that, very simple, Iran cannot have a nuclear weapon. I'm doing that for the world. I'm not doing it just for us. The Strait of Hormuz, one of the world's most critical oil choke points, remaining a major sticking point in the talks, asked whether he would accept even a short-term deal giving Iran and Oman, which both border the Strait of Hormuz, control over shipping routes, President Trump flatly rejecting the idea. Now, the strait's going to be open to everybody. It's, uh, it's internet. international waters. Nobody's going to control it. We're going to watch over it. We'll watch over it. But nobody's going to control it. That's part of the negotiation that we have. They would like to control it. Nobody's going to control it. It's international waters. And Oman will behave just like everybody else who will have to blow them up. They understand that.

Treasury Secretary Scott Besson attempting to assuage concerns about spiking gas prices, as the AAA National Gas average sits at $4.46. In terms of prices, I believe the prices are transitory. Oil will be lower than pre-conflict levels. When this ends, natural gas is already down. As you mentioned, drug and pharmaceutical prices, they are plummeting and rent is down. We are more resilient to energy price fluctuations due to your energy dominance agenda to regulatory efforts. And we have never sold so much energy to the rest of the world.

Secretary of State Marco Rubio also shifting the focus closer to home, outlining progress in Venezuela while warning that Cuba's worsening instability poses a growing national security concern for the United States. I think over 10 million barrels of Venezuelan oil had been delivered to the United States since the 3rd of January. That industry is being professionalized for the first time ever. It's going to the benefit of the Venezuelan people. They are selling oil in the market at market rates. Cuba's in a lot of trouble because, unfortunately, for them, it's run by. a bunch of incompetent communists.

And being communist is bad. Being an incompetent communist is like the worst. So we'll be talking to them, we'll be working on it. You know, we want something good for the Cuban people. And it's 90 miles from our shores. And having it a failed state, 90 miles from our shores is a threat

to the national security of the United States. Toward the end of the meeting, a more personal question. President Trump asked about the latest security scare near the White House, a gunman opening fire near a White House checkpoint over the weekend. The president was inside the residence at the time.

One bystander was struck, and the suspect was killed by officers returning fire. Here, the president. Well, I can't think about it because if I thought about it a lot, you know, I wouldn't be a very good president. I wouldn't be here, probably. It'd be up in some room with a locked door and say, just leave me alone. So I can't really think about it if it's such something that it's a sad part of life. It's a dangerous business.

What I'm doing is a dangerous. business and they say and look we have been maybe the most consequential but we certainly have been one of the most consequential this group has been a very consequential administration and they say if you're not consequential you don't have so much problem if you are consequential you do so you have to look at that but it's a shame it's a sad it's a very sad fact of life look anybody in office not only in this country in other countries too but when you all are a consequential president, your life is in grave danger. I knew that. Former Attorney General Pam Bondi revealing she has been diagnosed with thyroid cancer,

telling CNN she received the diagnosis after leaving the DOJ last month. Bondi says she is now in treatment and underwent surgery, telling the outlet she is still recovering, but, quote, doing well. The thyroid is a small endocrine gland at the front of the neck, producing hormones that help regulate metabolism, heart rate, body temperature, and other functions. According to the National Cancer Institute, thyroid cancer accounts for roughly 45,000 new cases a year in the U.S., with a 98% five-year survival rate. Bondi's diagnosis coming just weeks after President Trump removed her as Attorney General amid frustration from the president, especially relating to her handling of the Epstein files. At the time, President Trump posting to truth social that Bondi would be moving into a, quote,

much-needed and important private sector role, with details to come later. But Axios now reporting Bondi will return to the administration, President Trump appointing her to the Presidential Council of Advisors on Science and Technology, a panel of experts focused on the impact of emerging technologies like AI on American workers. The panel chaired by David Sachs and includes major tech figures such as meta-CEO Mark Zuckerberg and Oracle co-founder Larry Ellison. Bondi expected to serve as a liaison between the federal government and the executives advising the White House on technology policy. Vice President J.D. Vance releasing a statement, quote, Pam has been an enormously valuable asset to the president's team, and I'm thrilled for her and for all of us that she's going to remain involved in confronting some of the most important issues

the administration faces. Bondi is also scheduled to appear Friday before the House Oversight Committee as part of its Jeffrey Epstein probe. Coming up, new research suggesting weight-loss drugs like OZempec could do much more than help people lose weight. And NASA mapping out the next steps, toward putting astronauts back on the moon. What does it feel like when your clothes actually feel good?

This spring, cozy Earth, makes the case that what you wear at home matters just as much as what you wear out of the house, and maybe even more. Let me tell you about the brushed bamboo jogger set. Made from viscos from bamboo, it's lightweight, breathable, and unbelievably soft, with enough structure to feel put together, even at home. Or their lakehouse clogs. Designed for everyday home life, they feature a cushioned footbed, ultra-soft interior and easy slip-on design.

And with easy returns and a lifetime warranty, it's comfort worth upgrading to. Give yourself the kind of comfort that lives with you all day. Design to keep you cozy, comfortable, and actually relaxed all season long. Head on over to cozyEarth.com and use our code, Megan, for up to 30% off your order, but just for a limited time. This exclusive offer runs just through June 1st, okay,

through June 1st only, so do not wait. That's code Megan at cozyEarth.com. for up to 30% off. And if you see a post-purched survey, tell them that you heard about Cozy Earth right here. A promising new study suggesting popular weight loss and diabetes drugs may be linked to slower progression in four major cancers.

Breast, colorectal, lung and liver cancer. GLP1 drugs, including semi-glutide and terseptide, are best known through brand names like Ozepic, Wigovie, and Manjaro. Cleveland Clinic researchers analyzing data from more than 12,000 patients with stage 1 through stage 3 solid tumors, comparing patients who started GLP-1 medications after their cancer diagnosis, with similar patients taking another class of diabetes drugs, known as glyptins. The study-finding patients taking GLP-1s were significantly less likely

to see their cancer progress to stage 4 disease. The largest reduction seen in non-small cell lung cancer, where GLP-1 users were about 50% less likely to see their cancer spread, to other parts of the body compared with patients taking gliptones. Among breast cancer patients, a 43% lower risk, liver cancer patients seeing a 38% lower risk, and colorectal cancer patients with a 31% lower risk. Researchers also finding lower rates of spread in prostate, pancreatic, and kidney cancer among patients taking gLP ones, but those differences were not large enough to be considered statistically significant. Tumor biology may offer one clue, with better outcomes seen in

patients whose tumors had higher levels of GLP1 receptors, the proteins that allow cells to respond to GLP1 hormones and medications. Lead study author, Dr. Mark Orland, telling the American Society of Clinical Oncology Daily News, quote, these results deserve cautious optimism. For patients managing both diabetes and cancer, the possibility that their anti-diabetic medication may also be working in their favor is an encouraging finding. The study was retrospective, meaning it cannot prove the GLP1 drugs directly caused the improved outcomes. The results could have been influenced by other factors, including patients underlying health conditions, weight loss, and broader metabolic improvements after starting the drugs.

Dr. Orland noting the next step would be a randomized, controlled trial, where GLP1 use is assigned by researchers rather than simply observed in patient records. After Artemis 2 sent astronauts farther from Earth than any humans before them, NASA now turning to the next step in its moon-to-Mars plan, a new wave of lunar missions meant to test the landers, rovers, habitats, and power systems that could one day support a mission to Mars. On Tuesday, NASA administrator Jared Isaacman and other top officials awarding the latest round of lucrative contracts to the U.S. company set to provide

the equipment needed to pull off this historic achievement. Isaacman describing the brutal reality of the task ahead. We are leveraging the NASA playbook from the 1960s, figuring out what works and what doesn't in this epic science of survival because the moon base is as beautiful as it is hostile. In sunlight, the surface can heat to over 250 degrees. In darkness, it can drop well below minus 200. In the permanently shaded craters, areas of great interest that have been untouched by sunlight for millions, even billions of years, temperatures can fall well below minus 400 degrees. There is no atmosphere to moderate these extremes, no protect

from radiation and solar particle events, and the surface is exposed to meteorite impacts, including the kind of light flashes the Artemis 2 crew observed from orbit. The contracts totaling in the hundreds of millions of dollars, marking the first phase in NASA's projected $20 billion investment over the next seven years to establish a permanent moon base. Jeff Bezos's Blue Origin winning a $188 million contract, with a possible extension worth another $280.4 million to deliver NASA equipment to the Moon's south pole as soon as fall 2026. Company's Astrolav and Lunar Outpost awarded $219 million and $220 million, respectively, to develop and deliver NASA's first lunar terrain vehicles, giving astronauts and robotic missions the ability

to move across the moon's surface by 2028. The contracts tied to three missions, Moon Base 1, 2, and three, all targeted for launch this year, each aimed at testing a different piece of NASA's long-term plan for a permanent lunar presence. More from Isaacman. Moon Base One will be the first privately funded lunar lander mission in history. The mission objective is to demonstrate critical capabilities that reduce risk for the human landing system missions. Moonbase 2 will be the largest commercial payload delivered the lunar surface ever. The astrobotic Griffin-Lander will carry more than 500 kilograms of cargo. This mission will help mature the capabilities necessary to support future lunar terrain vehicles, autonomous operations, logistics, and especially the LTV astronaut mobility.

Moonbase 3 will expand our scientific understanding of the lunar surface. NASA planning to announce more than a dozen missions this year, all in preparation to return astronauts to the moon. The next crude mission, Artemis 3, is currently slated for mid-2020, and will focus on testing the the rendezvous and docking systems astronauts will need before attempting a lunar landing. If successful, that would set the stage for Artemis 4 in 2028, when NASA hopes to return humans to the surface of the moon for the first time since Apollo 17 in 1972. That'll do it for your AM update. I'm Emily Jershinsky, host of After Party. Catch the Megan Kelly Show live on SiriusXMs, the Megan Kelly Channel 11 at noon east on YouTube.com

slash Megan Kelly and all podcast platforms.